ACR Gears Up For Key State Legislative Issues Including AI
ACR joined physician leaders at the AMA summit to address Medicaid, payer issues, physician-led care, wellness, and emerging AI legislation in states.
Read more
The Biden Administration provided an update May 9 regarding the reignition of the Cancer Moonshot initiative, including more than 35 private sector organizations initiating new actions and collaborations to expand access to cancer screenings and prevent more cancers before they start. The Cancer Moonshot was originally launched in 2016, to accelerate progress against cancer; it was reignited by President Biden in 2021 to end cancer as we know it.
In the last two decades, the cancer death rate has decreased by more than 25%. The Cancer Moonshot initiative goal is to decrease cancer deaths by more than 50% in the next 10 years, but to do that, there must be more progress made toward prevention, detection and treatment.
Danielle Carnival, PhD, deputy assistant to the president for the Cancer Moonshot, last week highlighted the importance of accessibility to screenings and removing any barriers during a webinar hosted by The Hill. Carnival reported that although 10 million screenings were missed during the COVID-19 pandemic, the country is back to pre-COVID screening levels.
Also covered in the webinar, was support for federal funding as vital for sustained cancer research and access, including funding the National Institutes of Health and the Advanced Research Projects Agency for Health (ARPA-H), along with the Cancer Moonshot funding. The American College of Radiology® (ACR®) continues to advocate for increased funding for NIH, which includes the National Cancer Institute and ARPA-H.
For more information, contact Katie Grady, ACR Government Affairs Director.
ACR Gears Up For Key State Legislative Issues Including AI
ACR joined physician leaders at the AMA summit to address Medicaid, payer issues, physician-led care, wellness, and emerging AI legislation in states.
Read more
FDA Updates Guidance on Clinical Decision Support
FDA’s 2026 CDS update clarifies which software is regulated, affirming oversight of image‑analysis tools while exempting certain guideline‑based CDS.
Read moreStates Begin to Introduce Bills for 2026
States launch 2026 sessions with new bills on AI governance, rural radiation therapy, imaging workforce standards, and dose rules.
Read more